Glossary

Navigation title: 
Gene Therapy Education
Background video: 
Images: 
Show particles: 

Frequently Asked Questions

Navigation title: 
Gene Therapy Education
Background video: 
Images: 
Show particles: 

Gene transfer has the potential to address the genetic cause of Duchenne muscular dystrophy

Navigation title: 
Gene Therapy Education
Background video: 
Images: 
Show particles: 
Sep20

Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. 

Jul27

New data from the SGT-001 preclinical program was published today in Molecular Therapy – Methods and Clinical Development

Jun08

We are getting ready to initiate a clinical study for our gene transfer candidate, SGT-001, later this year.

Jun08

Solid Biosciences is pleased to announce additional research grant from our Australia-based partner Save Our Sons and an initial research grant from Ireland-based Join Our Boys.

Jun07
  • Jennifer Ziolkowski, CPA, joins as Chief Financial Officer.
  • Carl Morris, Ph.D., promoted to Chief Scientific Officer.
  • Joel Schneider, Ph.D., promoted to Chief Technology Officer, Head of Exploratory R&D.
May11

Solid Biosciences to Initiate Clinical Program for Gene Therapy Candidate in Coming Months

Pages

More information about Solid?

Please subscribe to receive our latest news